Join leading researchers as they reveal how targeted iPSC engineering is transforming disease modeling and accelerating discovery. Our two expert speakers will discuss how iPSCs are enabling highly specific control for more reproducible and patient relevant discovery.

• Learn how to engineer iPSCs with precise, multigene fluorescent tagging to create robust, disease-relevant cellular models

• Gain insights into using CRISPR-edited iPSCs to map genetic variants and uncover disease mechanisms

• Discover optimized workflows for culture and single-cell cloning across diverse cell types

• Understand how gentle microfluidic sorting enhances single-cell isolation to streamline workflows and produce more relevant disease models

Meet the Speakers:

Dr. Oscar Perez, MD PhD

Temple University School of Pharmacy

Dr. Chris Heger, PhD

R&D Systems